Behandlung und Vorbeugung von Nephrotoxin-Induzierten Nierenschäden
EP4772181
8. Juli 2026
Anmelder: Farsight Medical Technology (Shanghai) Co., Ltd. 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4772181
- Anmeldetag
- 12. Oktober 2020
- Veröffentlichung
- 8. Juli 2026
- Rechtsraum
- EP
- IPC
- A61K31/7036
Abstract
The invention provides for Compound I or a pharmaceutically acceptable salt thereof <img class="EMIRef" id="54bb05d6-0d35-4a02-bf20-1c596d2f7f8a-ia01" /> for use in the prevention and/or treatment of a kidney condition or disease in a subject exposed to a nephrotoxin capable of inducing said kidney condition or disease.
Anmelder
- Firma
- Farsight Medical Technology (Shanghai) Co., Ltd.
- Land
- 🇨🇳 China